Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Abstract Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed literature identified 41 relevant publications. Of these, 11 (mostly based on Mexican data) estimated the prevalence of SpA and its subtypes, which varied from 0.28 to 0.9% (SpA), 0.02 to 0.8% (ankylosing spondylitis), 0.2 to 0.9% (axial SpA), and 0.004 to 0.08% (psoriatic arthritis). Demographic and/or clinical characteristics were reported in 31 of the 41 publications, deriving data from 3 multinational studies, as well as individual studies from Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Uruguay, and Venezuela. Data relating to treatment, disease manifestations (articular and extra-articular), and comorbidities were summarized across the countries. Available data suggest that there is a variability in prevalence, manifestations, and comorbidities of SpA across Latin America. Basic epidemiologic and clinical data are required from several countries not currently represented. Data relating to current treatment approaches, patient outcomes, and socioeconomic impact within this large geographic region are also needed.

Saved in:
Bibliographic Details
Main Authors: Citera,Gustavo, Bautista-Molano,Wilson, Peláez-Ballestas,Ingris, Azevedo,Valderilio F., Perich,Risto A., Méndez-Rodríguez,José A., Cutri,Mariel S., Borlenghi,Cecilia E.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Reumatologia 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2523-31062021000100401
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2523-31062021000100401
record_format ojs
spelling oai:scielo:S2523-310620210001004012021-01-19Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritisCitera,GustavoBautista-Molano,WilsonPeláez-Ballestas,IngrisAzevedo,Valderilio F.Perich,Risto A.Méndez-Rodríguez,José A.Cutri,Mariel S.Borlenghi,Cecilia E. Prevalence Spondyloarthropathy Ankylosing spondylitis Psoriatic arthritis Latin America Abstract Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed literature identified 41 relevant publications. Of these, 11 (mostly based on Mexican data) estimated the prevalence of SpA and its subtypes, which varied from 0.28 to 0.9% (SpA), 0.02 to 0.8% (ankylosing spondylitis), 0.2 to 0.9% (axial SpA), and 0.004 to 0.08% (psoriatic arthritis). Demographic and/or clinical characteristics were reported in 31 of the 41 publications, deriving data from 3 multinational studies, as well as individual studies from Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Uruguay, and Venezuela. Data relating to treatment, disease manifestations (articular and extra-articular), and comorbidities were summarized across the countries. Available data suggest that there is a variability in prevalence, manifestations, and comorbidities of SpA across Latin America. Basic epidemiologic and clinical data are required from several countries not currently represented. Data relating to current treatment approaches, patient outcomes, and socioeconomic impact within this large geographic region are also needed.info:eu-repo/semantics/openAccessSociedade Brasileira de ReumatologiaAdvances in Rheumatology v.61 20212021-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2523-31062021000100401en10.1186/s42358-020-00161-5
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Citera,Gustavo
Bautista-Molano,Wilson
Peláez-Ballestas,Ingris
Azevedo,Valderilio F.
Perich,Risto A.
Méndez-Rodríguez,José A.
Cutri,Mariel S.
Borlenghi,Cecilia E.
spellingShingle Citera,Gustavo
Bautista-Molano,Wilson
Peláez-Ballestas,Ingris
Azevedo,Valderilio F.
Perich,Risto A.
Méndez-Rodríguez,José A.
Cutri,Mariel S.
Borlenghi,Cecilia E.
Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
author_facet Citera,Gustavo
Bautista-Molano,Wilson
Peláez-Ballestas,Ingris
Azevedo,Valderilio F.
Perich,Risto A.
Méndez-Rodríguez,José A.
Cutri,Mariel S.
Borlenghi,Cecilia E.
author_sort Citera,Gustavo
title Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_short Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_full Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_fullStr Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_full_unstemmed Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_sort prevalence, demographics, and clinical characteristics of latin american patients with spondyloarthritis
description Abstract Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed literature identified 41 relevant publications. Of these, 11 (mostly based on Mexican data) estimated the prevalence of SpA and its subtypes, which varied from 0.28 to 0.9% (SpA), 0.02 to 0.8% (ankylosing spondylitis), 0.2 to 0.9% (axial SpA), and 0.004 to 0.08% (psoriatic arthritis). Demographic and/or clinical characteristics were reported in 31 of the 41 publications, deriving data from 3 multinational studies, as well as individual studies from Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Uruguay, and Venezuela. Data relating to treatment, disease manifestations (articular and extra-articular), and comorbidities were summarized across the countries. Available data suggest that there is a variability in prevalence, manifestations, and comorbidities of SpA across Latin America. Basic epidemiologic and clinical data are required from several countries not currently represented. Data relating to current treatment approaches, patient outcomes, and socioeconomic impact within this large geographic region are also needed.
publisher Sociedade Brasileira de Reumatologia
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2523-31062021000100401
work_keys_str_mv AT citeragustavo prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT bautistamolanowilson prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT pelaezballestasingris prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT azevedovalderiliof prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT perichristoa prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT mendezrodriguezjosea prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT cutrimariels prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT borlenghiceciliae prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
_version_ 1756441918941691904